BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,735.35
- Market cap
- ₹4,285 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- -1073.9×Sector 37.9×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Evonile Pharma Fund Raise of ₹900 Cr
Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.
- Value
- ₹900.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Evonile Pharma Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹56.1 cr (-38% YoY) and PAT loss ₹77.5 cr, including ₹68 cr exceptional items. H1 revenue ₹159.9 cr (-10%). Transitioning to an independent branded pharma model; Minipress XL acquired.
Evonile Pharma Results Update
Evonile Pharma reported Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore. H1 FY27 profit after tax was a loss of ₹45.3 crore.
Evonile Pharma Investor Presentation: Key Takeaways
Q2 FY27 revenue fell 38% YoY to ₹56.1 cr, with a ₹77.5 cr net loss including ₹68 cr exceptional items. Transition from single-customer model to independent distribution continues.
Evonile Pharma Q2 FY27 Results: Net Loss of ₹77.5 Cr
Evonile Pharma posted a ₹775.4 million quarterly loss for September 2026 versus profit a quarter earlier. Exceptional items of ₹682.6 million drove the half-year pre-tax loss.
- Key figure
- Net loss ₹77.5 Cr
Other promoter selling (off-market) announcements
All →Gallantt Ispat Promoter Selling (Off-Market)
Promoter and director Dinesh R. Agarwal disposed of 50 lakh Gallantt Ispat shares by gift on November 3, 2026. His holding fell from 5.65% to 3.57%.
Gowra Leasing & Finance Promoter Selling (Off-Market)
Gowra Leasing promoter group members transferred 15,740 shares off-market, with no consideration paid. The transfer moved shares between promoter group members, so promoter holdings were redistributed.
Baba Arts Promoter Selling (Off-Market): ₹3.9 Cr
Promoter Gordhan Tanwani completed the off-market transfer of 65 lakh Baba Arts shares to Skybridge Interactive LLP. The final tranche is valued at Rs 3.90 Crore.
- Value
- ₹3.90 Cr
Shri Dinesh Mills Promoter Selling (Off-Market)
Promoter Arushaben Patel gifted all 7,68,852 Shri Dinesh Mills shares to promoter Nimish Patel in an inter-se transfer. No cash consideration was involved.
Castrol India Promoter Selling (Off-Market)
BP p.l.c. indirectly sold its 51% Castrol India stake via Castrol Group Holdings on October 30, 2026. Its holding falls to nil, with no stated consideration.
Shah Foods Promoter Selling (Off-Market): ₹1.76 Cr
Seven promoter group members sold 2,92,839 Tandhan Energies (formerly Shah Foods) shares off-market between October 9 and 14, 2026. Each seller's holding dropped to zero.
- Value
- ₹1.76 Cr